This work was supported by the Australian National Health and Medical Research Council (NHMRC fellowship #454330 to JX, project grant #628761 to SM and APP1058647 to JX), Multiple Sclerosis Research Australia (MSRA #12070 to JX), the University of Melbourne Research Grant Support Scheme and Melbourne Research CI Fellowship to JX as well as Australia Postgraduate Scholarships to HP and AF.&#160;We would like to acknowledge the Operational Infrastructure Scheme of the Department of Innovation, Industry and Regional Development, Victoria Australia.

<ol>
	<li>Baumann, N., Pham-Dinh, D. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Biology+of+oligodendrocyte+and+myelin+in+the+mammalian+central+nervous+system.">Biology of oligodendrocyte and myelin in the mammalian central nervous system.</a> Physiol Rev. 81 (2), 871-927 (2001).</li><li>Watkins, T. A., Emery, B., Mulinyawe, S., Barres, B. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Distinct+stages+of+myelination+regulated+by+gamma-secretase+and+astrocytes+in+a+rapidly+myelinating+CNS+coculture+system.">Distinct stages of myelination regulated by gamma-secretase and astrocytes in a rapidly myelinating CNS coculture system.</a> Neuron. 60 (4), 555-569 (2008).</li><li>Lee, K., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=MDGAs+interact+selectively+with+neuroligin-2+but+not+other+neuroligins+to+regulate+inhibitory+synapse+development.">MDGAs interact selectively with neuroligin-2 but not other neuroligins to regulate inhibitory synapse development.</a> Proc Natl Acad Sci U S A. 110 (1), 336-341 (2013).</li><li>Xiao, J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=BDNF+exerts+contrasting+effects+on+peripheral+myelination+of+NGF-dependent+and+BDNF-dependent+DRG+neurons.">BDNF exerts contrasting effects on peripheral myelination of NGF-dependent and BDNF-dependent DRG neurons.</a> J Neurosci. 29 (13), 4016-4022 (2009).</li><li>Chan, J. R., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=NGF+controls+axonal+receptivity+to+myelination+by+Schwann+cells+or+oligodendrocytes.">NGF controls axonal receptivity to myelination by Schwann cells or oligodendrocytes.</a> Neuron. 43 (2), 183-191 (2004).</li><li>Xiao, J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Brain-Derived+Neurotrophic+Factor+Promotes+Central+Nervous+System+Myelination+via+a+Direct+Effect+upon+Oligodendrocytes.">Brain-Derived Neurotrophic Factor Promotes Central Nervous System Myelination via a Direct Effect upon Oligodendrocytes.</a> Neurosignals. 18 (3), 186-202 (2010).</li><li>Lundgaard, I., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Neuregulin+and+BDNF+induce+a+switch+to+NMDA+receptor-dependent+myelination+by+oligodendrocytes.">Neuregulin and BDNF induce a switch to NMDA receptor-dependent myelination by oligodendrocytes.</a> PLoS Biology. 11 (12), e1001743 (2013).</li><li>Kleitman, N., W, P. M., Bunge, R. P. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=.">.</a> Tissue culture methodes for the study of myelination. , (1991).</li><li>Xiao, J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Extracellular+signal-regulated+kinase+1/2+signaling+promotes+oligodendrocyte+myelination+in+vitro.">Extracellular signal-regulated kinase 1/2 signaling promotes oligodendrocyte myelination in vitro.</a> J Neurochem. 122 (6), 1167-1180 (2012).</li><li>Wong, A. W., Xiao, J., Kemper, D., Kilpatrick, T. J., Murray, S. S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Oligodendroglial+expression+of+TrkB+independently+regulates+myelination+and+progenitor+cell+proliferation.">Oligodendroglial expression of TrkB independently regulates myelination and progenitor cell proliferation.</a> The Journal of Neuroscience. 33 (11), 4947-4957 (2013).</li><li>Li, Z., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Molecular+cloning,+Characterization+and+Expression+of+miR-15a-3p+and+miR-15b-3p+in+Dairy+Cattle.">Molecular cloning, Characterization and Expression of miR-15a-3p and miR-15b-3p in Dairy Cattle.</a> Molecular and Cellular Probes. , (2014).</li><li>Emery, B., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Myelin+gene+regulatory+factor+is+a+critical+transcriptional+regulator+required+for+CNS+myelination.">Myelin gene regulatory factor is a critical transcriptional regulator required for CNS myelination.</a> Cell. 138 (1), 172-185 (2009).</li><li>Murai, K., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Nuclear+receptor+TLX+stimulates+hippocampal+neurogenesis+and+enhances+learning+and+memory+in+a+transgenic+mouse+model.">Nuclear receptor TLX stimulates hippocampal neurogenesis and enhances learning and memory in a transgenic mouse model.</a> Proc Natl Acad Sci U S A. 111 (25), 9115-9120 (2014).</li></ol>

The authors declare that there is no conflict of interest regarding this research.

La myélinisation des axones est un processus crucial pour le fonctionnement optimal des deux systèmes nerveux central et périphérique de vertébrés. La génération et la maintenance des axones myélinisés est un processus complexe et coordonnée impliquant des interactions moléculaires entre neuronale, gliale (à partir de cellules de Schwann ou oligodendrocytes) et protéines de la matrice extra-cellulaire. L&#39;importance et l&#39;applicabilité de ce protocole est qu&#39;il permet la manipulation des protéi...

La myélinisation des axones est crucial pour la transmission rapide et efficace des potentiels d&#39;action dans les deux les systèmes nerveux central et périphérique. Des cellules spécialisées, les cellules de Schwann dans le système nerveux périphérique et les oligodendrocytes dans le système nerveux central, se enroulent autour des axones et ensheathe dans la myéline, efficace isolantes du nerf et de faciliter la conduction saltatoire 1. Le procédé de la myélinisation peut être étudiée in vitro en utilisant des neurones ganglionnaires de la rétine, 2 nanofibres par génie 3, ou neurones ganglionnaires de la racine dorsale co-cultivées avec des cellules de Schwann ou des oligodendrocytes 4 7.5. Le dosage in vitro de la myélinisation est un modèle établi pour l&#39;étude du système nerveux myélinisation et il reproduit la plupart des processus fondamentaux qui se produisent pendant la myélinisation in vivo 5-8. Le test implique la co-culture des populations purifiées de ganglions de racine dorsale (DRG) neurones, avec OPC (CNS myélinisation) ou des cellules de Schwann (PNS pour la myélinisation). Dans des conditions spécifiques de ces cellules myélinisantes ensheathe axones DRG dans l&#39;ordre, structurellement vérifié, feuille multi-lamellaire ultra de la membrane plasmique qui expriment la même complément de protéines spécifiques de la myéline présents in vivo isolant. Le modèle de cellule la plus couramment utilisée de l&#39;étude de myélinisation du SNC in vitro est le co-cultures de neurones DRG et OPC, qui ont été utilisés avec succès pour étudier l&#39;effet que des facteurs exogènes tels que les neurotrophines exercent sur ​​myélinisation du SNC in vitro 5,6. Les facteurs exogènes tels que les facteurs de croissance ou de petites molécules inhibiteurs pharmacologiques ont été largement utilisés pour étudier le rôle des voies de signalisation dans la myélinisation utilisant le DRG-OPC modèle de co-culture 7,9. Cependant, dans les paramètres de co-culture mixte contenant à la fois des neurones et des oligodendrocytes, il est resté formellement possible que soit les facteurs de croissance ou du pharinhibiteurs macologique auraient exercé des effets à la fois les neurones et les oligodendrocytes (OL) DRG. Cela offre la possibilité de disséquer spécifiquement les rôles que les protéines exprimées uniquement par DRG ou oligodendroglie exerce sur la myélinisation utilisant ce système cellulaire double. Pour confirmer sans équivoque que la voie de signalisation dans oligodendrogliale régule directement la myélinisation, transduction lentiviral des OPC, avant le semis sur les neurones de DRG pour le dosage in vitro de la myélinisation, se est avéré être une manière élégante de surexpression de type sauvage et les protéines mutantes, ainsi comme knockdown expression des protéines exprimées de manière constitutive par les oligodendrocytes. Ainsi, cette approche offre une avenue pour interroger et manipuler spécifiquement les voies de signalisation au sein oligodendrocytes pour étudier la myélinisation 9,10. Dans cet article, nous présentons les méthodes que nous avons développées pour surexprimer une protéine d&#39;intérêt dans les oligodendrocytes sélective via un lentivirusapproche pour étudier la myélinisation in vitro. La technique commence avec la génération de vecteurs d&#39;expression contenant le gène d&#39;intérêt, que ce soit dans un type sauvage, forme négative constitutivement active ou dominant qui sont ensuite ensuite clone dans le vecteur pENTR (pENTR L1-L2 pENTR4IRES2GFP). Ce vecteur (contenant le gène d&#39;intérêt), le donneur CMV promoteur (pENTR L4-R1 pENTR-pDNOR-CMV) et le lentivecteur de 2K7 sont combinés dans une réaction enzymatique pour produire un vecteur de 2K7 contenant le promoteur CMV, le gène d&#39;intérêt, un site interne d&#39;entrée des ribosomes et la GFP (Figure 1). Cette passerelle clone construction d&#39;2K7 combiné avec l&#39;enveloppe du virus PMD2.G et le paquet de virus pBR8.91 peut être co-transfecté dans des cellules HEK293T pour générer lentivirus qui peut ensuite être utilisé pour transduire des OPC. Une fois infectés par le lentivirus les OPC expriment un niveau élevé de la protéine d&#39;intérêt. Ces OPC peuvent ensuite être ensemencées sur les cultures de neurones DRG et l&#39;effet que l&#39;expressionles niveaux des élevés de la protéine désirée exerce sur la myélinisation peut être interrogé. Les co-cultures sont évaluées pour l&#39;expression de la protéine de myéline par analyse Western blot et visualisés pour la formation de segments axonales myélinisées par immunocytochimie.

<table border="0" cellpadding="0" cellspacing="0" width="843">
	<tbody>
		<tr height="21">
			<td height="21" style="height:21px;width:413px;">Item</td>
			<td style="width:148px;">Manufacturer</td>
			<td style="width:99px;">Catalog #</td>
			<td style="width:183px;">Notes</td>
		</tr>
		<tr height="25">
			<td height="25" style="height:25px;">2K7 lentivector&#160;</td>
			<td></td>
			<td></td>
			<td>Kind gift from Dr Suter9</td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">5-Fluoro-2&#8242;-deoxyuridine</td>
			<td>Sigma-Aldrich</td>
			<td>F0503-100mg</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">Alexa Fluor 488 Goat anti-mouse IgG</td>
			<td>Jackson Immunoresearch</td>
			<td>115545205</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">Alexa Fluor 488 goat anti-rabbit IgG (H+L)</td>
			<td>Life Technologies</td>
			<td>A11008</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">Alexa Fluor 594 goat anti-mouse IgG (H+L)</td>
			<td>Life Technologies</td>
			<td>A11005</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">Alexa Fluor 594 goat anti-rabbit IgG (H+L)</td>
			<td>Life Technologies</td>
			<td>A11012</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">Ampicillin</td>
			<td>Sigma-Aldrich</td>
			<td>A9518-5G</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">B27 - NeuroCul SM1 Neuronal Supplement</td>
			<td>Stem Cell Technologies&#160;</td>
			<td>5711</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">BDNF (Human)</td>
			<td>Peprotech</td>
			<td>PT450021000</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">Biotin (d-Biotin)</td>
			<td>Sigma Aldrich</td>
			<td>B4639</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">Bradford Reagent</td>
			<td>Sigma Aldrich</td>
			<td>B6916-500ML&#160;&#160;</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">BSA</td>
			<td>Sigma Aldrich</td>
			<td>A4161</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">Chloramphenicol</td>
			<td>Sigma-Aldrich</td>
			<td>C0378-100G</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">CNTF</td>
			<td>Peprotech</td>
			<td>450-13020</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">DAKO fluoresence mounting media</td>
			<td>DAKO</td>
			<td>S302380-2</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">DMEM, High Glucose, Pyruvate, no Glutamine</td>
			<td>Life Technologies</td>
			<td>10313039</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">DNase</td>
			<td>Sigma-Aldrich</td>
			<td>D5025-375KU</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">DPBS</td>
			<td>Life Technologies</td>
			<td>14190250</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">DPBS, calcium, magnesium</td>
			<td>Life Technologies</td>
			<td>14040182</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">EBSS</td>
			<td>Life Technologies</td>
			<td>14155063</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">EcoRI-HF</td>
			<td>NEB</td>
			<td>R3101</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">Entry vectors for promoter and gene of interest</td>
			<td></td>
			<td></td>
			<td>Generate as per protocols 1-2</td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">Fetal Bovine Serum</td>
			<td>Sigma-Aldrich</td>
			<td>12003C</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">Forskolin&#160;</td>
			<td>Sigma Aldrich</td>
			<td>F6886-50MG</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">Glucose (D-glucose)</td>
			<td>Sigma-Aldrich</td>
			<td>G7528</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">Glycerol</td>
			<td>Chem Supply</td>
			<td>GL010-500M</td>
			<td>See stock solutions</td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">Goat Anti-Mouse IgG</td>
			<td>Jackson ImmunoResearch</td>
			<td>115005003</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">Goat Anti-Mouse IgM&#160;</td>
			<td>Jackson ImmunoResearch</td>
			<td>115005020</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">Goat Anti-Rat IgG</td>
			<td>Jackson ImmunoResearch</td>
			<td>112005167</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">Hoechst 33342</td>
			<td>Life Technologies</td>
			<td>H3570</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">Igepal</td>
			<td>Sigma Aldrich</td>
			<td>I3021-100ML&#160;</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">Insulin&#160;</td>
			<td>Sigma Aldrich</td>
			<td>I6634&#160;</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">Kanamycin</td>
			<td>Sigma-Aldrich</td>
			<td>60615</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">Laminin&#160;</td>
			<td>Life Technologies</td>
			<td>23017015</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">LB Medium</td>
			<td></td>
			<td></td>
			<td>See stock solutions</td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">LB-Agar</td>
			<td></td>
			<td></td>
			<td>See stock solutions</td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">L-cysteine</td>
			<td>Sigma-Aldrich</td>
			<td>C-7477</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">Leibovitz&#39;s L-15 Medium</td>
			<td>Life Technologies</td>
			<td>11415064</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">L-Glutamate</td>
			<td>Sigma-Aldrich</td>
			<td>G1626</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">L-Glutamine- 200mM (100X) liquid</td>
			<td>Life Technologies</td>
			<td>25030081</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">LR Clonase II Plus enzyme</td>
			<td>Life Technologies</td>
			<td>12538-120</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">MEM, NEAA, no Glutamine</td>
			<td>Life Technologies</td>
			<td>10370088</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">Mouse &#945; &#946;III Tubulin&#160;</td>
			<td>Promega</td>
			<td>G7121</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">Mouse &#945;MBP (monoclonal)</td>
			<td>Millipore</td>
			<td>MAB381</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">Na pyruvate&#160;</td>
			<td>Life Technologies</td>
			<td>11360-070</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">NAC</td>
			<td>Sigma Aldrich</td>
			<td>A8199</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">NcoI-HF</td>
			<td>NEB</td>
			<td>R3193S</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">NEBuffer 4</td>
			<td>NEB</td>
			<td>B7004S</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">Neurobasal medium</td>
			<td>Life Technologies</td>
			<td>21103049</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">NGF (mouse)</td>
			<td>Alomone Labs</td>
			<td>N-100</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">NT-3</td>
			<td>Peprotech</td>
			<td>&#160;450-03</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">O1 antibody - Mouse anti-O1</td>
			<td>Millipore</td>
			<td>MAB344</td>
			<td>Alternative if O1 hybridoma cells are unavailable</td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">O1 hybridoma cells</td>
			<td></td>
			<td></td>
			<td>Conditioned medium containing anti-O1 antibody to be used for immunopanning</td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">O4 antibody - Mouse anti-O4</td>
			<td>Millipore</td>
			<td>MAB345</td>
			<td>Alternative if O4 hybridoma cells are unavailable</td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">O4 hybridoma cells</td>
			<td></td>
			<td></td>
			<td>Conditioned medium containing anti-O4 antibody to be used for immunopanning</td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">&#160;Competent Cells</td>
			<td>Life Technologies</td>
			<td>A10460</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">One Shot Stbl competent cells</td>
			<td>Life Technologies</td>
			<td>C7373-03</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">Papain Suspension</td>
			<td>Worthington/Cooper</td>
			<td>LS003126</td>
			<td></td>
		</tr>
		<tr height="25">
			<td height="25" style="height:25px;">pBR8.91</td>
			<td></td>
			<td></td>
			<td>Kind gift from Dr Denham10</td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">PDGF-AA (Human)</td>
			<td>Peprotech</td>
			<td>PT10013A500&#160;&#160;</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">Penicillin- Streptomycin 100X solution</td>
			<td>Life Technologies</td>
			<td>15140122</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">pENTRY4IRES2GFP</td>
			<td>Invitrogen</td>
			<td>11818-010&#160;</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">pMD2.G</td>
			<td>Addgene</td>
			<td>12259</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">Poly-D-lysine</td>
			<td>Sigma</td>
			<td>P6407-5MG</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">Polyethylenimine (PEI)&#160;</td>
			<td>Sigma-Aldrich</td>
			<td>408727-100ML</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">Poly-L-ornithine&#160;</td>
			<td>Sigma Aldrich&#160;</td>
			<td>P3655</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">Progesterone&#160;</td>
			<td>Sigma Aldrich</td>
			<td>P8783</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">Protease inhibitor tablet (Complete mini)</td>
			<td>Roche</td>
			<td>11836153001</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">Proteinase K</td>
			<td></td>
			<td></td>
			<td>Supplied with Clonase enzyme</td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">Putrescine</td>
			<td>Sigma Aldrich</td>
			<td>P-5780</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">Rabbit &#945; neurofilament</td>
			<td>Millipore</td>
			<td>AB1987&#160;&#160;</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">Rabbit &#945;MBP (polyclonal)</td>
			<td>Millipore</td>
			<td>AB980</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">Ran2 hybridoma cells</td>
			<td>ATCC</td>
			<td>TIB-119</td>
			<td>Conditioned medium containing anti-Ran2 antibody to be used for immunopanning</td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">Rat anti CD140A/PDGFRa antibody</td>
			<td>BD Pharmingen</td>
			<td>558774</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">SacII</td>
			<td>NEB</td>
			<td>R0157</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">SOC medium</td>
			<td></td>
			<td></td>
			<td>Supplied with competent bacteria</td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">Sodium selenite&#160;</td>
			<td>Sigma Aldrich</td>
			<td>S5261</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">Spe I</td>
			<td>NEB</td>
			<td>R0133S</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">T4 DNA Ligase</td>
			<td>NEB</td>
			<td>M0202S</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">T4 DNA Ligase Buffer</td>
			<td>NEB</td>
			<td>B0202S</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">TE buffer pH8</td>
			<td></td>
			<td></td>
			<td>See stock solutions</td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">TNE lysis buffer</td>
			<td></td>
			<td></td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">Trace Elements B</td>
			<td>Cellgro&#160;</td>
			<td>99-175-CI</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">Transferrin (apo-Transferrin human)</td>
			<td>Sigma-Aldrich</td>
			<td>T1147</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">Triton&#160;X-100</td>
			<td>Sigma-Aldrich</td>
			<td>T9284&#160;</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">Trypsin</td>
			<td>Sigma-Aldrich</td>
			<td>T9201-1G</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">Trypsin Inhibitor From Chicken Egg White</td>
			<td>Roche</td>
			<td>10109878001</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">Trypsin-EDTA (1X), phenol red (0.05%)</td>
			<td>Life Technologies</td>
			<td>25300-054</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">Unconjugated Griffonia Simplicifolia Lectin BSL-1</td>
			<td>Vector laboratories&#160;</td>
			<td>L-1100</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;">Uridine</td>
			<td>Sigma-Aldrich</td>
			<td>U3003-5G</td>
			<td></td>
		</tr>
	</tbody>
</table>

production and use of lentivirus to selectively transduce primary oligodendrocyte precursor cells for in vitro myelination assays

La myélinisation est un processus complexe qui implique à la fois les neurones et la myéline formant des cellules gliales, les oligodendrocytes dans le système nerveux central (SNC) et les cellules de Schwann dans le système nerveux périphérique (SNP). Nous utilisons un test in vitro de la myélinisation, un modèle établi pour étudier myélinisation du SNC in vitro. Pour ce faire, les cellules précurseurs d&#39;oligodendrocytes (OPC) sont ajoutés aux primaires rongeurs ganglion de racine dorsale (DRG) neurones purifiés pour former des co-cultures myélinisantes. Pour interroger spécifiquement les rôles que les protéines exprimées par les oligodendrocytes particuliers exercent sur la myélinisation nous avons développé des protocoles qui transduction sélective OPC à l&#39;aide du lentivirus surexprimant type sauvage, les protéines négatives dominantes ou constitutivement active avant d&#39;être ensemencées sur les neurones DRG. Cela nous permet d&#39;interroger spécifiquement les rôles de ces protéines dans la régulation oligodendrogliales myélinisation. Les protocoles peuvent également être appliqués dans l&#39;étude des OTses types cellulaires, offrant ainsi une approche qui permet la manipulation sélective des protéines exprimées par un type cellulaire souhaité, tels que les oligodendrocytes ciblée pour l&#39;étude de la signalisation et des mécanismes de compensation. En conclusion, combinant le dosage de la myélinisation in vitro avec lentiviraux infectés OPC fournit un outil stratégique pour l&#39;analyse des mécanismes moléculaires impliqués dans la myélinisation.

Le drapeau marqués kinase 1 (Flag-Erk1) liés signal construction utilisé pour la production lentivirus est vérifiée par l&#39;enzyme de restriction digérer des constructions utilisées, y compris les constructions d&#39;2K7 et les emballages et accessoires constructions nécessaires à la production de virus extracellulaire (figure 3) . <img alt="Figure 3" src="/files/ftp_upload/52179/52179fig3highres.jpg" /> Figure 3:...

Watch this Scientific Journal Video about Production and Use of Lentivirus to Selectively Transduce Primary Oligodendrocyte Precursor Cells for In Vitro Myelination Assays at JoVE.com

Production and Use of Lentivirus to Selectively Transduce Primary Oligodendrocyte Precursor Cells for In Vitro Myelination Assays

Here we present protocols that offer a flexible and strategic foundation for virally manipulating oligodendrocyte precursor cells to overexpress proteins of interest in order to specifically interrogate their role in oligodendrocytes via the in vitro model of central nervous system myelination.

Production et utilisation de lentivirus à des cellules sélective transduction primaire Oligodendrocyte précurseur pour<em&gt; In Vitro</em&gt; Les dosages de la myélinisation

Myelination is a complex process that involves both neurons and the myelin forming glial cells, oligodendrocytes in the central nervous system (CNS) and ...

production-use-lentivirus-to-selectively-transduce-primary

Research

JoVE Journal

Developmental Biology

Production and Use of Lentivirus to Selectively Transduce Primary Oligodendrocyte Precursor Cells for In Vitro Myelination Assays

14.4K vues.  The University of Melbourne. Here we present protocols that offer a flexible and strategic foundation for virally manipulating oligodendrocyte precursor cells to overexpress proteins of interest in order to specifically interrogate their role in oligodendrocytes via the in vitro model of central nervous system myelination.

Vidéo: Production and Use of Lentivirus to Selectively Transduce Primary Oligodendrocyte Precursor Cells for In Vitro Myelination Assays

Characterization of Thymic Settling Progenitors in the Mouse Embryo Using In Vivo and In Vitro Assays

Characterizing thymic settling progenitors is important to understand the pre-thymic stages of T cell development, essential to devise strategies for T cell replacement in lymphopenic patients. We studied thymic settling progenitors from murine embryonic day 13 and 18 thymi by two complementary in vitro and in vivo techniques, both based on the &#8220;hanging drop&#8221; method. This method allowed colonizing irradiated fetal thymic lobes with E13 and/or E18 thymic progenitors distinguished by CD45 allotypic markers and thus following their progeny. Colonization with mixed populations allows analyzing cell autonomous differences in biologic properties of the progenitors while colonization with either population removes possible competitive selective pressures. The colonized thymic lobes can also be grafted in immunodeficient male recipient mice allowing the analysis of the mature T cell progeny in vivo, such as population dynamics of the peripheral immune system and colonization of different tissues and organs. Fetal thymic organ cultures revealed that E13 progenitors developed rapidly into all mature CD3+ cells and gave rise to the canonical &#947;&#948; T cell subset, known as dendritic epithelial T cells. In comparison, E18 progenitors have a delayed differentiation and were unable to generate dendritic epithelial T cells. The monitoring of peripheral blood of thymus-grafted CD3-/- mice further showed that E18 thymic settling progenitors generate, with time, larger numbers of mature T cells than their E13 counterparts, a feature that could not be appreciated in the short term fetal thymic organ cultures.

Characterization of Thymic Settling Progenitors in the Mouse Embryo Using In Vivo and In Vitro Assays

This article describes in vivo and in vitro methodology to characterize the thymic settling progenitors by the analysis of the kinetics of generation, phenotype and numbers of their T cell progeny.

Caractérisation des progéniteurs thymique décantation dans l&#39;embryon de souris Utilisation<em&gt; In Vivo</em&gt; Et<em&gt; In Vitro</em&gt; Essais

Characterizing thymic settling progenitors is important to understand the pre-thymic stages of T cell development, essential to devise strategies for T ...

Recherche

Biologie du développement

In Vitro Colony Assays for Characterizing Tri-potent Progenitor Cells Isolated from the Adult Murine Pancreas

Stem and progenitor cells from the adult pancreas could be a potential source of therapeutic beta-like cells for treating patients with type 1 diabetes. However, it is still unknown whether stem and progenitor cells exist in the adult pancreas. Research strategies using cre-lox lineage-tracing in adult mice have yielded results that either support or refute the idea that beta cells can be generated from the ducts, the presumed location where adult pancreatic progenitors may reside. These in vivo cre-lox lineage-tracing methods, however, cannot answer the questions of self-renewal and multi-lineage differentiation-two criteria necessary to define a stem cell. To begin addressing this technical gap, we devised 3-dimensional colony assays for pancreatic progenitors. Soon after our initial publication, other laboratories independently developed a similar, but not identical, method called the organoid assay. Compared to the organoid assay, our method employs methylcellulose, which forms viscous solutions that allow the inclusion of extracellular matrix proteins at low concentrations. The methylcellulose-containing assays permit easier detection and analyses of progenitor cells at the single-cell level, which are critical when progenitors constitute a small sub-population, as is the case for many adult organ stem cells. Together, results from several laboratories demonstrate in vitro self-renewal and multi-lineage differentiation of pancreatic progenitor-like cells from mice. The current protocols describe two methylcellulose-based colony assays to characterize mouse pancreatic progenitors; one contains a commercial preparation of murine extracellular matrix proteins and the other an artificial extracellular matrix protein known as a laminin hydrogel. The techniques shown here are 1) dissociation of the pancreas and sorting of CD133+Sox9/EGFP+ ductal cells from adult mice, 2) single cell manipulation of the sorted cells, 3) single colony analyses using microfluidic qRT-PCR and whole-mount immunostaining, and 4) dissociation of primary colonies into single-cell suspensions and re-plating into secondary colony assays to assess self-renewal or differentiation.

In Vitro Colony Assays for Characterizing Tri-potent Progenitor Cells Isolated from the Adult Murine Pancreas

In vitro colony assays to detect self-renewal and differentiation of progenitor cells isolated from adult murine pancreas are devised. In these assays, pancreatic progenitors give rise to cell colonies in 3-dimensional space in methylcellulose-containing semi-solid medium. Protocols for handling single cells and characterization of individual colonies are described.

In Vitro Colony Assays pour Caractériser les cellules progénitrices Tri-puissants Isolée des adultes murins Pancréas

Stem and progenitor cells from the adult pancreas could be a potential source of therapeutic beta-like cells for treating patients with type 1 diabetes. ...

Preparation and Culture of Myogenic Precursor Cells/Primary Myoblasts from Skeletal Muscle of Adult and Aged Humans

Skeletal muscle homeostasis depends on muscle growth (hypertrophy), atrophy and regeneration. During ageing and in several diseases, muscle wasting occurs. Loss of muscle mass and function is associated with muscle fiber type atrophy, fiber type switching, defective muscle regeneration associated with dysfunction of satellite cells, muscle stem cells, and other pathophysiological processes. These changes are associated with changes in intracellular as well as local and systemic niches. In addition to most commonly used rodent models of muscle ageing, there is a need to study muscle homeostasis and wasting using human models, which due to ethical implications, consist predominantly of in vitro cultures. Despite the wide use of human Myogenic Progenitor Cells (MPCs) and primary myoblasts in myogenesis, there is limited data on using human primary myoblast and myotube cultures to study molecular mechanisms regulating different aspects of age-associated muscle wasting, aiding in the validation of mechanisms of ageing proposed in rodent muscle. The use of human MPCs, primary myoblasts and myotubes isolated from adult and aged people, provides a physiologically relevant model of molecular mechanisms of processes associated with muscle growth, atrophy and regeneration. Here we describe in detail a robust, inexpensive, reproducible and efficient protocol for the isolation and maintenance of human MPCs&#160;and their progeny&#160;&#8212; myoblasts and myotubes from human muscle samples using enzymatic digestion. Furthermore, we have determined the passage number at which primary myoblasts from adult and aged people undergo senescence in an in vitro culture. Finally, we show the ability to transfect these myoblasts and the ability to characterize their proliferative and differentiation capacity and propose their suitability for performing functional studies of molecular mechanisms of myogenesis and muscle wasting in vitro.

This protocol describes a robust, reproducible and simple method of isolation and culture of myoblast progenitor cells from the skeletal muscle of adult and aged people. The muscles used here include foot and leg muscles. This approach enables the isolation of an enriched population of primary myoblasts for functional studies.

Préparation et culture de cellules Myogenic Précurseurs / myoblastes primaires de muscle squelettique des adultes et les humains âgés

Skeletal muscle homeostasis depends on muscle growth (hypertrophy), atrophy and regeneration. During ageing and in several diseases, muscle wasting ...

Reprogramming Primary Amniotic Fluid and Membrane Cells to Pluripotency in Xeno-free Conditions

Autologous cell-based therapies got a step closer to reality with the introduction of induced pluripotent stem cells. Fetal stem cells, such as amniotic fluid and membrane mesenchymal stem cells, represent a unique type of undifferentiated cells with promise in tissue engineering and for reprogramming into iPSC for future pediatric interventions and stem cell banking. The protocol presented here describes an optimized procedure for extracting and culturing primary amniotic fluid and membrane mesenchymal stem cells and generating episomal induced pluripotent stem cells from these cells in fully chemically defined culture conditions utilizing human recombinant vitronectin and the E8 medium. Characterization of the new lines by applying stringent methods &#8211; flow cytometry, confocal imaging, teratoma formation and transcriptional profiling &#8211; is also described. The newly generated lines express markers of embryonic stem cells &#8211; Oct3/4A, Nanog, Sox2, TRA-1-60, TRA-1-81, SSEA-4 &#8211; while being negative for the SSEA-1 marker. The stem cell lines form teratomas in scid-beige mice in 6-8 weeks and the teratomas contain tissues representative of all three germ layers. Transcriptional profiling of the lines by submitting global expression microarray data to a bioinformatic pluripotency assessment algorithm deemed all lines pluripotent and therefore, this approach is an attractive alternative to animal testing. The new iPSC lines can readily be used in downstream experiments involving the optimization of differentiation and tissue engineering.

This protocol describes the reprogramming of primary amniotic fluid and membrane mesenchymal stem cells into induced pluripotent stem cells using a non-integrating episomal approach in fully chemically defined conditions. Procedures of extraction, culture, reprogramming, and characterization of the resulting induced pluripotent stem cells by stringent methods are detailed.

Reprogrammation du liquide amniotique primaire et cellules de Membrane de pluripotence dans des Conditions sans Xeno

Autologous cell-based therapies got a step closer to reality with the introduction of induced pluripotent stem cells. Fetal stem cells, such as amniotic ...

Rapid Detection of Neurodevelopmental Phenotypes in Human Neural Precursor Cells (NPCs)

Human brain development proceeds through a series of precisely orchestrated processes, with earlier stages distinguished by proliferation, migration, and neurite outgrowth; and later stages characterized by axon/dendrite outgrowth and synapse formation. In neurodevelopmental disorders, often one or more of these processes are disrupted, leading to abnormalities in brain formation and function. With the advent of human induced pluripotent stem cell (hiPSC) technology, researchers now have an abundant supply of human cells that can be differentiated into virtually any cell type, including neurons. These cells can be used to study both normal brain development and disease pathogenesis. A number of protocols using hiPSCs to model neuropsychiatric disease use terminally differentiated neurons or use 3D culture systems termed organoids. While these methods have proven invaluable in studying human disease pathogenesis, there are some drawbacks. Differentiation of hiPSCs into neurons and generation of organoids are lengthy and costly processes that can impact the number of experiments and variables that can be assessed. In addition, while post-mitotic neurons and organoids allow the study of disease-related processes, including dendrite outgrowth and synaptogenesis, they preclude the study of earlier processes like proliferation and migration. In neurodevelopmental disorders, such as autism, abundant genetic and post-mortem evidence indicates defects in early developmental processes. Neural precursor cells (NPCs), a highly proliferative cell population, may be a suitable model in which to ask questions about ontogenetic processes and disease initiation. We now extend methodologies learned from studying development in mouse and rat cortical cultures to human NPCs. The use of NPCs allows us to investigate disease-related phenotypes and define how different variables (e.g., growth factors, drugs) impact developmental processes including proliferation, migration, and differentiation in only a few days. Ultimately, this toolset can be used in a reproducible and high-throughput manner to identify disease-specific mechanisms and phenotypes in neurodevelopmental disorders.

Rapid Detection of Neurodevelopmental Phenotypes in Human Neural Precursor Cells NPCs

Neurodevelopmental processes such as proliferation, migration, and neurite outgrowth are often perturbed in neuropsychiatric diseases. Thus, we present protocols to rapidly and reproducibly assess these neurodevelopmental processes in human iPSC-derived NPCs. These protocols also allow the assessment of the effects of relevant growth factors and therapeutics on NPC development.

Détection rapide des phénotypes de développement neurologique dans des cellules précurseurs neurales humaines (PNJ)

Human brain development proceeds through a series of precisely orchestrated processes, with earlier stages distinguished by proliferation, migration, and ...

Application of RNAi and Heat-shock-induced Transcription Factor Expression to Reprogram Germ Cells to Neurons in C. elegans

Studying the cell biological processes during converting the identities of specific cell types provides important insights into mechanism that maintain and protect cellular identities. The conversion of germ cells into specific neurons in the nematode Caenorhabditis elegans (C. elegans) is a powerful tool for performing genetic screens in order to dissect regulatory pathways that safeguard established cell identities. Reprogramming of germ cells to a specific type of neurons termed ASE requires transgenic animals that allow broad over-expression of the Zn-finger transcription factor (TF) CHE-1. Endogenous CHE-1 is expressed exclusively in two head neurons and is required to specify the glutamatergic ASE neurons fate, which can easily be visualized by the gcy-5prom::gfp reporter. A trans gene containing the heat-shock promoter-driven che-1 gene expression construct allows broad mis-expression of CHE-1 in the entire animal upon heat-shock treatment. The combination of RNAi against the chromatin-regulating factor LIN-53 and heat-shock-induced che-1 over-expression leads to reprogramming of germ cell into ASE neuron-like cells. We describe here the specific RNAi procedure and appropriate conditions for heat-shock treatment of transgenic animals in order to successfully induce germ cell to neuron conversion.

Application of RNAi and Heat-shock-induced Transcription Factor Expression to Reprogram Germ Cells to Neurons in C. elegans

This protocol describes how to study cellular processes during cell fate conversion in Caenorhabditis elegans in vivo. Using transgenic animals, allowing heat-shock promoter-driven overexpression of the neuron fate-inducing transcription factor CHE-1 and RNAi-mediated depletion of the chromatin-regulating factor LIN-53 germ cell to neuron reprogramming can be observed in vivo.

Application de RNAi et Expression du facteur de Transcription induite par la chaleur-choc pour reprogrammer les cellules germinales de neurones chez c. elegans

Studying the cell biological processes during converting the identities of specific cell types provides important insights into mechanism that maintain ...

Single-cell Photoconversion in Living Intact Zebrafish

Animal and plant tissue is composed of distinct populations of cells. These cells interact over time to build and maintain the tissue and can cause disease when disrupted. Scientists have developed clever techniques to investigate characteristics and natural dynamics of these cells within intact tissue by expressing fluorescent proteins in subsets of cells. However, at times, experiments require more selected visualization of cells within the tissue, sometimes at the single-cell or population-of-cells manner. To achieve this and visualize single cells within a population of cells, scientists have utilized single-cell photoconversion of fluorescent proteins. To demonstrate this technique, we show here how to direct UV light to an Eos-expressing cell of interest in an intact, living zebrafish. We then image those photoconverted Eos+ cells 24 h later to determine how they changed in the tissue. We describe two techniques: single cell photoconversion and photoconversions of populations of cell. These techniques can be used to visualize cell-cell interactions, cell-fate and differentiation, and cell migrations, making it a technique that is applicable in numerous biological questions.

Here, we present a protocol to show how cell photoconversion is achieved through UV exposure to specific areas expressing the fluorescent protein, Eos, in living animals.

Photoconversion cellule unique chez le poisson zèbre Intact de la vie

Animal and plant tissue is composed of distinct populations of cells. These cells interact over time to build and maintain the tissue and can cause ...

Computational Analysis of the Caenorhabditis elegans Germline to Study the Distribution of Nuclei, Proteins, and the Cytoskeleton

The Caenorhabditis elegans (C. elegans) germline is used to study several biologically important processes including stem cell development, apoptosis, and chromosome dynamics. While the germline is an excellent model, the analysis is often two dimensional due to the time and labor required for three-dimensional analysis. Major readouts in such studies are the number/position of nuclei and protein distribution within the germline. Here, we present a method to perform automated analysis of the germline using confocal microscopy and computational approaches to determine the number and position of nuclei in each region of the germline. Our method also analyzes germline protein distribution that enables the three-dimensional examination of protein expression in different genetic backgrounds. Further, our study shows variations in cytoskeletal architecture in distinct regions of the germline that may accommodate specific spatial developmental requirements. Finally, our method enables automated counting of the sperm in the spermatheca of each germline. Taken together, our method enables rapid and reproducible phenotypic analysis of the C. elegans germline.

Computational Analysis of the Caenorhabditis elegans Germline to Study the Distribution of Nuclei, Proteins, and the Cytoskeleton

We present an automated method for three-dimensional reconstruction of the Caenorhabditis elegans germline. Our method determines the number and position of each nucleus within the germline and analyses germline protein distribution and cytoskeletal structure.

Analyse de calcul de la lignée germinale de Caenorhabditis elegans pour étudier la Distribution des noyaux, les protéines et le cytosquelette

The Caenorhabditis elegans (C. elegans) germline is used to study several biologically important processes including stem cell development, apoptosis, and ...

Induction and Validation of Cellular Senescence in Primary Human Cells

Cellular senescence is a state of permanent cell cycle arrest activated in response to different damaging stimuli. Activation of cellular senescence is a hallmark of various pathophysiological conditions including tumor suppression, tissue remodeling and aging. The inducers of cellular senescence in vivo are still poorly characterized. However, a number of stimuli can be used to promote cellular senescence ex vivo. Among them, most common senescence-inducers are replicative exhaustion, ionizing and non-ionizing radiation, genotoxic drugs, oxidative stress, and demethylating and acetylating agents. Here, we will provide detailed instructions on how to use these stimuli to induce fibroblasts into senescence. This protocol can easily be adapted for different types of primary cells and cell lines, including cancer cells. We also describe different methods for the validation of senescence induction. In particular, we focus on measuring the activity of the lysosomal enzyme Senescence-Associated &#946;-galactosidase (SA-&#946;-gal), the rate of DNA synthesis using 5-ethynyl-2&#39;-deoxyuridine (EdU) incorporation assay, the levels of expression of the cell cycle inhibitors p16 and p21, and the expression and secretion of members of the Senescence-Associated Secretory Phenotype (SASP). Finally, we provide example results and discuss further applications of these protocols.

Here, we discuss a series of protocols for induction and validation of cellular senescence in cultured cells. We focus on different senescence-inducing stimuli and describe the quantification of common senescence-associated markers. We provide technical details using fibroblasts as a model, but the protocols can be adapted to various cellular models.

Induction et la Validation de la sénescence cellulaire dans les cellules humaines primaires

Cellular senescence is a state of permanent cell cycle arrest activated in response to different damaging stimuli. Activation of cellular senescence is a ...

In Vitro Assays to Evaluate the Migration, Invasion, and Proliferation of Immortalized Human First-trimester Trophoblast Cell Lines

Cell movement is a critical property of trophoblasts during placental development and early pregnancy. The significance of proper trophoblast migration and invasion is demonstrated by pregnancy disorders such as pre-eclampsia and intrauterine growth restriction, which are associated with inadequate trophoblast invasion of the maternal vasculature. Unfortunately, our understanding of the mechanisms by which the placenta develops from migrating trophoblasts is limited. In vitro analysis of cell migration via the scratch assay is a useful tool in identifying factors that regulate trophoblast migratory capacity. However, this assay alone does not define the cellular changes that can result in altered cell migration. This protocol describes three different in vitro assays that are used collectively to evaluate trophoblast cell movement: the scratch assay, the invasion assay, and the proliferation assay. The protocols described here may also be modified for use in other cell lines to quantify cell movement in response to stimuli. These methods allow investigators to identify individual factors that contribute to the cell movement and provide a thorough examination of potential mechanisms underlying apparent changes in cell migration.

Here, we present a highly accessible protocol for evaluating the cell movement in human trophoblast cells using three in vitro assays: the scratch assay, the transwell invasion assay, and the cell proliferation assay.

Tests in Vitro pour évaluer la Migration, Invasion et la prolifération de lignées cellulaires immortalisées humaine au premier trimestre trophoblaste

Cell movement is a critical property of trophoblasts during placental development and early pregnancy. The significance of proper trophoblast migration ...